Close
Achema middle east
swop processing & packaging

Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

As the U.S. production investments continue to roll in...

AstraZeneca Plant Expansion to Double Production of Lokelma

AstraZeneca has gone on to announce a newly expanded manufacturing...

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Precision Formulation in Personalized Medicine

Personalized Medicine and the Future of Precision Formulation The medical...

Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.

Earlier, the company has received a warning letter from the agency on 25 August 2010 for violating good manufacturing practice regulations. The issuance of the letter follows FDA inspection of the site.

Caraco, now wholly owned by Sun Pharma, continues to work with consultants to resolve the issues raised by the FDA at its Detroit plant.

Latest stories

Related stories

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

As the U.S. production investments continue to roll in...

AstraZeneca Plant Expansion to Double Production of Lokelma

AstraZeneca has gone on to announce a newly expanded manufacturing...

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Precision Formulation in Personalized Medicine

Personalized Medicine and the Future of Precision Formulation The medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »